NCT06852846View on ClinicalTrials.gov

Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Febrile Illness

Interventions

DIAGNOSTIC_TEST

Biological sample

Biomarker test for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), interferon gamma-inducible protein of 10 kDa (IP-10), and C-reactive protein

Trial Locations (1)

Unknown

Meyer Children's Hospital IRCCS, Firenze, Florence

All Listed Sponsors

lead

Meyer Children's Hospital IRCCS

OTHER

NCT06852846 - Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children | Biotech Hunter | Biotech Hunter